Randomised Controlled Trial of sedation for colonoscopy: Entonox versus Midazolam/Fentanyl

ISRCTN ISRCTN81142957
DOI https://doi.org/10.1186/ISRCTN81142957
Secondary identifying numbers N0084160165
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
25/06/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Mr Graeme Duthie
Scientific

Acadmemic Surgical Unit
Hull and East Yorkshire Hospitals (NHS) Trust
Castle Hill Hospital
Hull
HU16 5JQ
United Kingdom

Phone +44 (0)1482 623247
Email G.S.Duthie@hull.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Scientific title
Study hypothesisDoes nitrous oxide (Entonox) provide better pain relief than the conventional intravenous sedation during colonoscopy
Ethics approval(s)Not provided at time of registration
ConditionSurgery: Sedation
InterventionProspective randomised controlled study. Pilot study initially involving 100 patients to determine statistical power.
Pts will be randomised using the sealed envelope method of block randomisation. Patients randomised to the entonox group will be taught methods of use. Patients will be shown the visual analogue score for pain and asked to mark them.
Those randomised to conventional intravenous sedation will be informed of same and will undergo colonoscopy using standard intravenous sedation protocols.
Entonox group encouraged to inhale the nitrous oxide for a full 60 seconds initially and then as and when required throughout procedure. Post colonoscopy both groups will be asked to indicate pain using visual analogue scale in the recovery.
Intervention typeProcedure/Surgery
Primary outcome measurePain score assessed by VAS
Secondary outcome measuresNot provided at time of registration
Overall study start date11/03/2005
Overall study end date10/02/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Participant inclusion criteriaAll patients undergoing elective colonoscopy would be prospective participants.
Participant exclusion criteria1. History of chronic respiratory disease
2. History of colonic resection
3. Intolerance to the drugs
4. Patients with pre-existing adbominal or perianal pain
5. Unwilling participants
Recruitment start date11/03/2005
Recruitment end date10/02/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Acadmemic Surgical Unit
Hull
HU16 5JQ
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

The North and South Bank Research and Development Consortium (UK) - NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results conference proceedings 01/04/2009 No No